Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02219087 · ClinicalTrials.gov registry record · NA
Liposomal Bupivacaine Versus Standard of Care in Total Knee Surgery
A NA study, sponsored by OhioHealth.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02219087 is a NA study that has completed, run by OhioHealth. The registered enrollment target is 60 participants.
The verdict
NCT02219087, a NA study, has completed, sponsored by OhioHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether liposomal bupivacaine is effective in the management of pain following total knee arthroplasty, as compared to standard of care analgesia.
Interventions
- DRUG Standard of Care
- DRUG Liposomal bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02219087
The ClinicalTrials.gov registry entry for NCT02219087 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OhioHealth, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT02219087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02219087 about?
NCT02219087 is a clinical study titled "Liposomal Bupivacaine Versus Standard of Care in Total Knee Surgery". The purpose of this study is to determine whether liposomal bupivacaine is effective in the management of pain following total knee arthroplasty, as compared to standard of care analgesia.
What is the current status of trial NCT02219087?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2014-08. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02219087?
The interventions under investigation include: Standard of Care (DRUG), Liposomal bupivacaine (DRUG).
Who is sponsoring clinical trial NCT02219087?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.